{"ticker": {"uuid": "d302e92e-0d9f-411a-8823-7efba73d07cd", "symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "3 Reasons to Buy Bristol Myers Squibb Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxORUpKQ19CbndxREU4RkxxRkRBazR3NDRiMXVHQVdtYUE5VEdQRlY4dEZWR0JVUk5TZ0NOWXdkVkp4bmtQU1FfNlZLMG5qbmhUa3hWSmF5ekc1NUxqaTFTNEo5ZVU1N1kyaEswaGRMbUEtNVdTZk9zeGloSUZrU2wtR3E4ald0LVFaay1SX1RxTVdNRGEtbFE?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-22T19:53:00+00:00", "published_display": "22 Jun 2026 19:53", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day", "summary": "Bristol Myers Squibb Co. (BMY) shares rose 1.30% to $54.70 on Monday, outperforming its competitors during a mixed trading session. This gain broke a four-day losing streak for the stock. The Dow Jones Industrial Average saw a slight increase, while the S&P 500 Index experienced ", "url": "https://www.marketwatch.com/data-news/bristol-myers-squibb-co-stock-outperforms-competitors-on-strong-trading-day-f5d480b8-93ba73f1c632?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-22T16:38:00", "published_display": "22 Jun 2026 16:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Harnessing the Potential of Anti-Cancer Modalities", "summary": "Bristol Myers Squibb (BMS) is developing new anti-cancer modalities, including antibody-drug conjugates (ADCs), protein degraders, and CAR T cell therapy, to combat aggressive and treatment-resistant cancers. ADCs use targeted drug delivery by combining antibodies with potent pay", "url": "https://www.bms.com/our-science/scientific-resources/anti-cancer-advanced-modalities.html", "source_name": "Bristol Myers Squibb", "published_at": "2026-06-22T10:07:55", "published_display": "22 Jun 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Barclays Bullish on Bristol-Myers Squibb (BMY) Now", "summary": "Barclays recently upgraded Bristol-Myers Squibb (BMY) to a \"Strong-Buy\" due to renewed confidence in its late-stage pipeline, strategic initiatives, and a stronger 2026 outlook. Despite patent cliffs for key drugs, BMY's R&D, new product launches, acquisitions, and a 4.0% dividen", "url": "https://www.kavout.com/market-lens/why-is-barclays-bullish-on-bristol-myers-squibb-bmy-now", "source_name": "Kavout", "published_at": "2026-06-21T00:07:15", "published_display": "21 Jun 2026 00:07", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Stock - Weekly review and sector comparison after a quiet news week", "summary": "Bristol Myers Squibb (BMY) stock had a quiet week with limited company-specific headlines, closing at $54.10 on June 18, 2026. The stock's performance was stable in comparison to its healthcare peers and the broader US equity market. Analysts maintain a \"Hold\" rating with an aver", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bristol-myers-squibb-stock-weekly-review-and-sector-comparison-after-a/69585559", "source_name": "AD HOC NEWS", "published_at": "2026-06-19T20:07:16", "published_display": "19 Jun 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb declares $0.63 quarterly dividend", "summary": "Bristol Myers Squibb (NYSE:BMY) has declared a quarterly dividend of $0.63 per share, payable on August 3, 2026, to stockholders of record on July 2, 2026. This extends their 56-year streak of consecutive dividend payments, with the stock currently yielding 4.51%. The company als", "url": "https://www.investing.com/news/company-news/bristol-myers-squibb-declares-063-quarterly-dividend-93CH-4748268", "source_name": "Investing.com", "published_at": "2026-06-18T17:37:14", "published_display": "18 Jun 2026 17:37", "sentiment": "positive", "sentiment_pct": 72, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day", "summary": "Bristol Myers Squibb Co. (BMY) shares decreased by 2.32% to $54.00, marking the fourth consecutive day of losses. Despite this, the stock underperformed the broader market, as the S&P 500 Index (SPX) rose by 1.08% and the Dow Jones Industrial Average (DJIA) increased by 0.14% on ", "url": "https://www.marketwatch.com/data-news/bristol-myers-squibb-co-stock-outperforms-competitors-despite-losses-on-the-day-3e2c3a65-eee09b61d814?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-18T16:38:00", "published_display": "18 Jun 2026 16:38", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026", "summary": "Bristol Myers Squibb (NYSE: BMY) announced it will release its second quarter 2026 financial results on Thursday, July 30, 2026. Company executives will host a conference call at 8:15 a.m. ET to discuss the results, with a live audio webcast available for investors and the public", "url": "https://www.businesswire.com/news/home/20260618405841/en/Bristol-Myers-Squibb-to-Report-Results-for-Second-Quarter-2026-on-July-30-2026", "source_name": "Business Wire", "published_at": "2026-06-18T11:00:13", "published_display": "18 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb (BMY) Maintains Quarterly Dividend at $0.63 per Share", "summary": "Bristol-Myers Squibb (BMY) announced a quarterly dividend of $0.63 per share, maintaining its previous payout, which results in a forward yield of 4.56%. The company, a significant player in the biopharmaceutical sector with a market cap of $112.89 billion, shows strong profitabi", "url": "https://www.gurufocus.com/news/8922185/bristolmyers-squibb-bmy-maintains-quarterly-dividend-at-063-per-share", "source_name": "GuruFocus", "published_at": "2026-06-18T06:16:13", "published_display": "18 Jun 2026 06:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EHA26: BMS touts positive multiple myeloma data for two pipeline candidates", "summary": "Bristol Myers Squibb (BMS) presented positive clinical trial data for two of its multiple myeloma (MM) pipeline candidates, mezigdomide and arlocabtagene autoleucel (arlo-cel), at EHA 2026. The Phase III SUCCESSOR-2 trial showed mezigdomide extended progression-free survival sign", "url": "https://www.clinicaltrialsarena.com/analyst-comment/eha26-bms-touts-positive-multiple-myeloma-data-for-two-pipeline-candidates/", "source_name": "Clinical Trials Arena", "published_at": "2026-06-18T03:37:43", "published_display": "18 Jun 2026 03:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Reports Strong Myeloma Trial Results And Early CAR T Progress", "summary": "Bristol Myers Squibb (BMY) announced positive late-stage clinical trial results for two multiple myeloma treatments, mezigdomide and their CAR T-cell therapy, arlocabtagene autoleucel. These results, presented at the European Hematology Association Congress 2026, suggest strong p", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb/news/bristol-myers-squibb-bmy-reports-strong-myeloma-trial-result", "source_name": "Simply Wall Street", "published_at": "2026-06-18T01:26:12", "published_display": "18 Jun 2026 01:26", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Stock Could Be 12.2% Undervalued on Pipeline and Margin Hopes", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSmZkb01pQU9MRTJPVTJlZ3hnODBvUHRiRlJPalJ6ZXoyNDNvcTMwMTBZMWtpbXJ5TkJnNUp4aENJR1NoTF9BbnVwclpxSzR3WWhZS1Nhdmh2ZF9YXzRGaWpKa0ZNcWltSk1SZVVPMW1MRlBOYTNBMXZTdHJONGtZRDJ1MjZ6YXg1S0lRa0FNbmt6dkpvVVJsZHhkQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-17T23:20:51+00:00", "published_display": "17 Jun 2026 23:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Unveils Myeloma Trial Win And New Gulf Leadership", "summary": "Bristol Myers Squibb (BMY) announced positive Phase III trial results for a multiple myeloma treatment and encouraging early data for a new CAR T-cell therapy, bolstering its hematology pipeline. The company also appointed a new General Manager for the Gulf region, signaling a st", "url": "https://sg.finance.yahoo.com/news/bristol-myers-squibb-bmy-unveils-221505394.html", "source_name": "Market source", "published_at": "2026-06-17T22:15:10", "published_display": "17 Jun 2026 22:15", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Stock Moves -1.14%: What You Should Know", "summary": "Bristol Myers Squibb (BMY) stock recently decreased by 1.14%, closing at $55.28, which slightly outperformed the S&P 500's larger daily loss. The company's upcoming earnings are projected to show a 10.27% increase in EPS, although revenue is expected to decline by 4.89%. Analysts", "url": "https://sg.finance.yahoo.com/news/bristol-myers-squibb-bmy-stock-214505113.html", "source_name": "Market source", "published_at": "2026-06-17T22:07:10", "published_display": "17 Jun 2026 22:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Declares Quarterly Dividend, Payable on August 3, 2026", "summary": "Bristol Myers Squibb has declared a quarterly dividend of $0.63 per share, as announced by its Board of Directors. This dividend is scheduled to be paid on August 3, 2026, to stockholders who are on record by the close of business on July 2, 2026. The company's stock is listed on", "url": "https://www.marketscreener.com/news/bristol-myers-squibb-declares-quarterly-dividend-payable-on-august-3-2026-ce7f5cddd980f226", "source_name": "marketscreener.com", "published_at": "2026-06-17T21:07:10", "published_display": "17 Jun 2026 21:07", "sentiment": "positive", "sentiment_pct": 65, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 per Share, Payable August 3 to shareholders of Record July 2", "summary": "Bristol-Myers Squibb (NYSE: BMY) has declared a quarterly dividend of $0.63 per share. This dividend will be payable on August 3 to shareholders of record as of July 2. The pharmaceutical company continues to maintain its steady dividend payouts.", "url": "https://www.marketscreener.com/news/bristol-myers-squibb-keeps-quarterly-dividend-at-0-63-per-share-payable-august-3-to-shareholders-o-ce7f5cddd98ff227", "source_name": "marketscreener.com", "published_at": "2026-06-17T20:39:27", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Announces Dividend", "summary": "Bristol Myers Squibb (BMY) has announced a dividend. This news is a brief update from Reuters, indicating a financial action by the company.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_TUAGPRJN:0-bristol-myers-squibb-announces-dividend/", "source_name": "TradingView", "published_at": "2026-06-17T20:16:14", "published_display": "17 Jun 2026 20:16", "sentiment": "positive", "sentiment_pct": 69, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNbVJXaTY2YkFjX2tldXpxcGpqRm9QRjB4d0ExLUFLWUM5Ym5ubHAzSmdXdk5vb1hrY2NmeC15bG9JS2lZLWFiampjeFh5T3d1eFlfMUVMUlVRRk85M0ppWDllaDlNcHdMR2RfUnpBYmpMT1JmOWV0WU1UUElhSFFpVzBjeWZNWUxnTXVoVTNUb04?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-06-17T13:00:04+00:00", "published_display": "17 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb price gives in to negative pressures - Forecast today - 16-06-2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQeXlLWnJyV25ySU9JNXFnSkQ4TWZQTHE0Vm01SlU2X2dMSFd2YTZxUTNHeTBISGtmNnQ3a3NyZ21BbC0ybnJXbW5ETjV2dGptb21mVFJvMzNKNkpPUmhGcC1KNGQ5TG1hYWRlV0tqYmxVOEctdnlsMk5nOExITEc2ZUtWcVE4Y3p6aDdlQTM5aF9MQ1lqLWlQTTZVMW5uSmdwTk94bzFGa3JNN3A0aHBUWHBTTDNvWmUzZ2s0Z044TnVZYjJycUFGS2wzQU0yMGNKcnFmazJ5S3R2c1A0T3RNTjRRX2k?oc=5", "source_name": "Economies.com", "published_at": "2026-06-16T13:04:00+00:00", "published_display": "16 Jun 2026 13:04", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Stock Could Be 10.7% Undervalued After Kidney Cancer Trial Expansion", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T11:37:22+00:00", "published_display": "16 Jun 2026 11:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Bristol Myers Squibb (BMY) Valuation After Fresh EU Opdivo Approval And New Phase 3 Oncology Data", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T03:36:20+00:00", "published_display": "06 Jun 2026 03:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOLXppNTl1Y0tPaDhXYVJPQ3RUdDA2TVF0YXRldkFOMEJiclE2a3ZXZUFPRkctZ19CRU9JVVdEdElfbHZSN2NKUWRydktMQ00zdm1neWZXTnROb2pyUmM5Ukw0d3FfVl9SM182YkJfN3hjNmtlRGxKY1NjdXNNaVRxVUNadU1FWkdaS1ItV2l1RmNPM2MwQzFtdWJldmg5eDd1VzJB?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: This Pullback Is A Gift For Long-Term Investors (NYSE:BMY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNbU5xN1ZXQ04wWFkwWkE3UThEbVQ3Tl9VQnp6aENOd2tITlRzVEtLT3NMUXREZF9XWk5WRnlKVEotZ3BVdHE4d0JOb3F0elNLLXB0MF82dVpZQlBZdWRyZVlBNnZDVUg1eEtkdl95MXNkN0RrQUZ6Y0ZOYVJUMFlqT3RWM2Vjajdfa2lMdFZ4QUEtYS0tY3RqWVBVcGhCTkp0NmNVM2NHdzVfNmZZWmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bristol-Myers Squibb Stock Underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNZnhCckt2ZlV3Q05hcG5TTVRWVy1xeW1QRWhqaHdXYmtoN2JhYzhXWXh2UTdDOVA4NHIxTEV3WExFS3kzbGRNZDd2d3FKS25yRllpR3VTbGNIVkxGZVo5MTRFdUppcW5jcGJFcEhJSFJFS1ppeXgxb2NrVjhHQkV1LXFSOVBoZ1hHdWVfeXEta004OEdjNXpJOWg3S095aFhpUTYzWEZtX3pHMzA?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSlV5MHVNekNvcy15RXBQdml3eVRkSC01RWJQazVrN3J2Q0ZEUnl5ZXNSNXUtdjViVWN1NHNENjdvMmFDQjVoZXNnc29yRVBVQ3Q1WmoybkVYSkVwd2ZvaF9sMldyM1dLTWM3NXZNbmRVeFVSZXcxTkdiWTY2ZVRsbkRUY2lVWXZ1SEk4dGRSa2ZlcndJakQ0Q2lNcTUyR1ZabnJXa1NxckxoUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQYnVXTkZrUW5ZTDI1UVE1OXdFRVItb3N4akhQOXRTOHZSYndGd1JUcllEN0pHUnRkdlluSHI0ZFliQTRyTlp1NTc3MnNLeVotekxQdy1NQk4zMzNtc1FzM2wzNUVxZEF1b3B1TmVEUWtWdU9hU2VCWnlLNUEyLVpoZDZQUEJodkJ2Nzd3UHY4VUFxQ0JiV0ZVU2p4VzhMcTFr?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS reiterates Bristol-Myers Squibb stock rating on pipeline potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZDJxc3p0MUE4TTA1VVhmTHZBTVU5NFl3OFpLOHpicWh5WnJ6bHhFZzNidGpLV2NJRXh6cnN5QmstQ094bkdyQ1JKRmZwZjVQZnNJV3RtRmI5RHg4RWVMM2dQeWFjUFYwRXpNZEo5Q3J6N1AyWUNBTnNZUHZ1WjhmOWU3cHZTZVZTLXdCaktDbHZyMHljVGJiVzdwVmNwVENFZElHNF9iOEU1N3RTUTUyTi1TeGdJYUJxWEJ2aVVDTjlZTEtkQjhBVA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Made Its Pipeline Case at BofA. Now Comes the Proof.", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ0RDUllpczhkczI2MUptb2tNOEFfY0J1eU1PR0dVbTZBdDZJeWdpMnlUUjQxU0E3OUlzS3pUQXYzZ3FOYlZHQjJaOXliVzN3NG9odmhlNzdidlE2Wm1QbDBZS0xtQ3R2TkdCSzBMMkpwYWxyODk1NWY0Y0l4c084OVdkNElfOThqV21JakRSRVZPNjhVMFJaamV6dHAwUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift Accurately", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5-Day Sell-Off Sends Bristol-Myers Squibb Stock Down -7.2%", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQRU5kTWFBSzhhTW02aXZ3YXFtQ3VvVHhpZGVVM0FTd0pfNWRKSi1iTFZoQURZQ0g2TmVSeVdaWkt3VkotQlh0bmJZSm1tR0NDUFZRTGotWXhrSzFLZTFKUFVoYlBsN3h4RW9lRWMtMkdxb0FkNzBlVlZaSHlPM3JIamsxaWh1NjFnTmptc3V2bG1qU2dWT2x5MFhtNm9OcEtZR1BtQWRsakhVeGlMVW45c3lwU3M1NVE?oc=5", "source_name": "Trefis", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQcHVJWjhMT1ZVOVVZWXl0ejJQUlQ4ckJuemNESVRiam5hRkRnT1hEbDByNWdYSUdHeTlpclo1VUtVamtvaVo4MXdhRnJtT3QwU0czZXRycnBjS1RrM2doYnBUWTI1UDlWMTZGUURib3pXeUZKR2cxNVZYbEtVcllVSmVkRkgxNWs1TlF6em9uMnlPUktPa3YtOUJQcm5TLXJyR3JuQVIyeDRFeUlreFJIXzR1RTk2MVM0SFVMWXo3d2QwLTE4Q2RDMEROR09jRHp4ZjU0R05DN3lFVUxDY1JvM3U5UkZ6QdIB6wFBVV95cUxNVW5jMXpjbmw0SHJ2SzN1VFltTUdHbks4TGZIWmhoS2JWbGRZdnVTN3VQS2VKS3JLTzFtWGtMRnRPUkV5bUxvcGJXejgzOF8xeE14OGROR0FSMDhTSTdldVJRU1BUbXVERTdPcnFpQ1NDb1JSR2JlRmxRek14czVxSTZ4Qko5dlhKMDY5UEwzeGhIWW5mWHU1N0pRbEJ0Q1I1UldYVmctRC1RbTBvV2w1QlFTVlVlbHctcXlPcXgtNkFCQjhDdXp1ZVJ2dmlGX01QQ0NLaEozT3FVUGV6YmFNMkY0dWFmVExTWldz?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.18% on May 1: Drivers Behind the Movement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQc25ZX1NFZ1dVRTdERzJMZXlHSlFNME1sdXFBcG4xeTREWTR3ZkxsUmZHODhCbHVvYWUwUHptV3FueWU0MGRocGR5YkZSMXF4S1BrNV9qZGlLclZtaDNpdUFRVzkxbTlJdXRNRS14Uk8tU0hTVjViWm15eE1fbk1xWXlhQy1ReXpVd3c?oc=5", "source_name": "TradingKey", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Earnings: Steady Quarter Ahead of Multiple Late-Stage Readouts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxOMzdRdl8tTFUxclFnNFc2OC1TZmw4bXZMY1RfX0l2Umk4VDNDNlItaXNVbEZIWWZIUWpfZlczSnVrQ2JLSlo1Y0lqYmowYzlDV002WVV3STVqTng4VWtMQVBjUTRuaEVCdWVoaXVtalJNRklnSEp6LWJkcFlMR0R3ZHpNdHRLWHlna2stU1JzSGtjaWEyRG9Cb2hfZ3RuU0lQWlltOGo1QXJmTzNSR2otWjJaZ0JwLWhicHVWX2xTNER6Q1hHa2NJTnJlRHY3NzVUNkdYZHpQbDNqTXU5dGVUZU5sY1dDeVFO?oc=5", "source_name": "Morningstar", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: Value Stock Analysis for Dividend Investors in 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxORVJTMFFLdjhIRzlaempPalJuQ3YxSkEwLXFkZ2xyblBwOHdsWXpvbmozbHFkLXNNLWJxUUctOVlaYllwa1I3NEFtLVkybG4yQXFHZVRRTTZ2endOeHFaQTIxSDhkZ0hobjk5b3l6VDRvSnR0Sk1YdVBVUXNwUUQxa1gweXJMVV9ncXVnUC1FZlZXdw?oc=5", "source_name": "IndexBox", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPZmJKQ3l2S2FkYjlsd0xiQWUwX1V5d3R2cEMzblBrVmNTUEdtdWFndkl6UnAyOTVQYW96VGdiQzlaX3dwQ0FjSUNHVE9mSy1kLTlhX29HUmFfcG55ZlRRV2lfcGl2S2l5ZXc0TUZwcmFxRGFHVjJyWW9EMXk4UVFWRUxQMEZybElFTll6NjNsNUxKcUJ6cEE2aTZPYXpMYXhYRm51LTRlRHp2RXIzQjFfSG1Wc3pVcFkyRVZaUjduTjFOWlZ5TmV1Q1VKWUdPREtlbW5sX3c3MkltOWVXRWlHMEdUSnBBTllFRjQ3bFkwSndnc2FiZFlkOHhB?oc=5", "source_name": "StockStory", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxObGRGcDE1QmFuUy1IX0l2TjZoeUptM3lLTlJxZjRBNjlvY01CT0pnTzVRN1EwU2pvRERsQUFTTENEU0VVUTB5TlZXQU5YWnVXVnY4bnNlNHg3c0wxakJ1NG0xV3FRZFFFYTRCSGMyc3dINmxkeXNHVXJUTTIycFR5U1F6Y3M1dmJzMjJTM1JETmswTHpaSjNmYnlaeXA0Zw?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bristol-Myers Squibb (BMY) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbDNiVDQ1OWZITy1VZXJIUURiOXBvSDZfSTA4Q0ZOTkotRks1a2tqOEJpYU9zSFpSWWxvdlVBQXFxRjFyWWdtMkI4Y1d0MHQyN2pyaS1hN0Q2Rm5uUkVpQXREZU9QS2lrSG5sbG14SkZRUXZ3eGN5UktRWUhTcmU1STdueXJsQ0FKajUxYWhKUkVUNFpNVzhlOWpnNGdBOENhWTFxemVDMEx3c1U?oc=5", "source_name": "StockStory", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Like Bristol-Myers Squibb's (NYSE:BMY) Earnings For More Than Just Statutory Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "3 Reasons to Buy Bristol Myers Squibb Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxORUpKQ19CbndxREU4RkxxRkRBazR3NDRiMXVHQVdtYUE5VEdQRlY4dEZWR0JVUk5TZ0NOWXdkVkp4bmtQU1FfNlZLMG5qbmhUa3hWSmF5ekc1NUxqaTFTNEo5ZVU1N1kyaEswaGRMbUEtNVdTZk9zeGloSUZrU2wtR3E4ald0LVFaay1SX1RxTVdNRGEtbFE?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-22T19:53:00+00:00", "published_display": "22 Jun 2026 19:53", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day", "summary": "Bristol Myers Squibb Co. (BMY) shares rose 1.30% to $54.70 on Monday, outperforming its competitors during a mixed trading session. This gain broke a four-day losing streak for the stock. The Dow Jones Industrial Average saw a slight increase, while the S&P 500 Index experienced ", "url": "https://www.marketwatch.com/data-news/bristol-myers-squibb-co-stock-outperforms-competitors-on-strong-trading-day-f5d480b8-93ba73f1c632?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-22T16:38:00", "published_display": "22 Jun 2026 16:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Harnessing the Potential of Anti-Cancer Modalities", "summary": "Bristol Myers Squibb (BMS) is developing new anti-cancer modalities, including antibody-drug conjugates (ADCs), protein degraders, and CAR T cell therapy, to combat aggressive and treatment-resistant cancers. ADCs use targeted drug delivery by combining antibodies with potent pay", "url": "https://www.bms.com/our-science/scientific-resources/anti-cancer-advanced-modalities.html", "source_name": "Bristol Myers Squibb", "published_at": "2026-06-22T10:07:55", "published_display": "22 Jun 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Barclays Bullish on Bristol-Myers Squibb (BMY) Now", "summary": "Barclays recently upgraded Bristol-Myers Squibb (BMY) to a \"Strong-Buy\" due to renewed confidence in its late-stage pipeline, strategic initiatives, and a stronger 2026 outlook. Despite patent cliffs for key drugs, BMY's R&D, new product launches, acquisitions, and a 4.0% dividen", "url": "https://www.kavout.com/market-lens/why-is-barclays-bullish-on-bristol-myers-squibb-bmy-now", "source_name": "Kavout", "published_at": "2026-06-21T00:07:15", "published_display": "21 Jun 2026 00:07", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Stock - Weekly review and sector comparison after a quiet news week", "summary": "Bristol Myers Squibb (BMY) stock had a quiet week with limited company-specific headlines, closing at $54.10 on June 18, 2026. The stock's performance was stable in comparison to its healthcare peers and the broader US equity market. Analysts maintain a \"Hold\" rating with an aver", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bristol-myers-squibb-stock-weekly-review-and-sector-comparison-after-a/69585559", "source_name": "AD HOC NEWS", "published_at": "2026-06-19T20:07:16", "published_display": "19 Jun 2026 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb declares $0.63 quarterly dividend", "summary": "Bristol Myers Squibb (NYSE:BMY) has declared a quarterly dividend of $0.63 per share, payable on August 3, 2026, to stockholders of record on July 2, 2026. This extends their 56-year streak of consecutive dividend payments, with the stock currently yielding 4.51%. The company als", "url": "https://www.investing.com/news/company-news/bristol-myers-squibb-declares-063-quarterly-dividend-93CH-4748268", "source_name": "Investing.com", "published_at": "2026-06-18T17:37:14", "published_display": "18 Jun 2026 17:37", "sentiment": "positive", "sentiment_pct": 72, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day", "summary": "Bristol Myers Squibb Co. (BMY) shares decreased by 2.32% to $54.00, marking the fourth consecutive day of losses. Despite this, the stock underperformed the broader market, as the S&P 500 Index (SPX) rose by 1.08% and the Dow Jones Industrial Average (DJIA) increased by 0.14% on ", "url": "https://www.marketwatch.com/data-news/bristol-myers-squibb-co-stock-outperforms-competitors-despite-losses-on-the-day-3e2c3a65-eee09b61d814?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-18T16:38:00", "published_display": "18 Jun 2026 16:38", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026", "summary": "Bristol Myers Squibb (NYSE: BMY) announced it will release its second quarter 2026 financial results on Thursday, July 30, 2026. Company executives will host a conference call at 8:15 a.m. ET to discuss the results, with a live audio webcast available for investors and the public", "url": "https://www.businesswire.com/news/home/20260618405841/en/Bristol-Myers-Squibb-to-Report-Results-for-Second-Quarter-2026-on-July-30-2026", "source_name": "Business Wire", "published_at": "2026-06-18T11:00:13", "published_display": "18 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb (BMY) Maintains Quarterly Dividend at $0.63 per Share", "summary": "Bristol-Myers Squibb (BMY) announced a quarterly dividend of $0.63 per share, maintaining its previous payout, which results in a forward yield of 4.56%. The company, a significant player in the biopharmaceutical sector with a market cap of $112.89 billion, shows strong profitabi", "url": "https://www.gurufocus.com/news/8922185/bristolmyers-squibb-bmy-maintains-quarterly-dividend-at-063-per-share", "source_name": "GuruFocus", "published_at": "2026-06-18T06:16:13", "published_display": "18 Jun 2026 06:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EHA26: BMS touts positive multiple myeloma data for two pipeline candidates", "summary": "Bristol Myers Squibb (BMS) presented positive clinical trial data for two of its multiple myeloma (MM) pipeline candidates, mezigdomide and arlocabtagene autoleucel (arlo-cel), at EHA 2026. The Phase III SUCCESSOR-2 trial showed mezigdomide extended progression-free survival sign", "url": "https://www.clinicaltrialsarena.com/analyst-comment/eha26-bms-touts-positive-multiple-myeloma-data-for-two-pipeline-candidates/", "source_name": "Clinical Trials Arena", "published_at": "2026-06-18T03:37:43", "published_display": "18 Jun 2026 03:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Reports Strong Myeloma Trial Results And Early CAR T Progress", "summary": "Bristol Myers Squibb (BMY) announced positive late-stage clinical trial results for two multiple myeloma treatments, mezigdomide and their CAR T-cell therapy, arlocabtagene autoleucel. These results, presented at the European Hematology Association Congress 2026, suggest strong p", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb/news/bristol-myers-squibb-bmy-reports-strong-myeloma-trial-result", "source_name": "Simply Wall Street", "published_at": "2026-06-18T01:26:12", "published_display": "18 Jun 2026 01:26", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Stock Could Be 12.2% Undervalued on Pipeline and Margin Hopes", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSmZkb01pQU9MRTJPVTJlZ3hnODBvUHRiRlJPalJ6ZXoyNDNvcTMwMTBZMWtpbXJ5TkJnNUp4aENJR1NoTF9BbnVwclpxSzR3WWhZS1Nhdmh2ZF9YXzRGaWpKa0ZNcWltSk1SZVVPMW1MRlBOYTNBMXZTdHJONGtZRDJ1MjZ6YXg1S0lRa0FNbmt6dkpvVVJsZHhkQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-17T23:20:51+00:00", "published_display": "17 Jun 2026 23:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Unveils Myeloma Trial Win And New Gulf Leadership", "summary": "Bristol Myers Squibb (BMY) announced positive Phase III trial results for a multiple myeloma treatment and encouraging early data for a new CAR T-cell therapy, bolstering its hematology pipeline. The company also appointed a new General Manager for the Gulf region, signaling a st", "url": "https://sg.finance.yahoo.com/news/bristol-myers-squibb-bmy-unveils-221505394.html", "source_name": "Market source", "published_at": "2026-06-17T22:15:10", "published_display": "17 Jun 2026 22:15", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Stock Moves -1.14%: What You Should Know", "summary": "Bristol Myers Squibb (BMY) stock recently decreased by 1.14%, closing at $55.28, which slightly outperformed the S&P 500's larger daily loss. The company's upcoming earnings are projected to show a 10.27% increase in EPS, although revenue is expected to decline by 4.89%. Analysts", "url": "https://sg.finance.yahoo.com/news/bristol-myers-squibb-bmy-stock-214505113.html", "source_name": "Market source", "published_at": "2026-06-17T22:07:10", "published_display": "17 Jun 2026 22:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Declares Quarterly Dividend, Payable on August 3, 2026", "summary": "Bristol Myers Squibb has declared a quarterly dividend of $0.63 per share, as announced by its Board of Directors. This dividend is scheduled to be paid on August 3, 2026, to stockholders who are on record by the close of business on July 2, 2026. The company's stock is listed on", "url": "https://www.marketscreener.com/news/bristol-myers-squibb-declares-quarterly-dividend-payable-on-august-3-2026-ce7f5cddd980f226", "source_name": "marketscreener.com", "published_at": "2026-06-17T21:07:10", "published_display": "17 Jun 2026 21:07", "sentiment": "positive", "sentiment_pct": 65, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 per Share, Payable August 3 to shareholders of Record July 2", "summary": "Bristol-Myers Squibb (NYSE: BMY) has declared a quarterly dividend of $0.63 per share. This dividend will be payable on August 3 to shareholders of record as of July 2. The pharmaceutical company continues to maintain its steady dividend payouts.", "url": "https://www.marketscreener.com/news/bristol-myers-squibb-keeps-quarterly-dividend-at-0-63-per-share-payable-august-3-to-shareholders-o-ce7f5cddd98ff227", "source_name": "marketscreener.com", "published_at": "2026-06-17T20:39:27", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb Announces Dividend", "summary": "Bristol Myers Squibb (BMY) has announced a dividend. This news is a brief update from Reuters, indicating a financial action by the company.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_TUAGPRJN:0-bristol-myers-squibb-announces-dividend/", "source_name": "TradingView", "published_at": "2026-06-17T20:16:14", "published_display": "17 Jun 2026 20:16", "sentiment": "positive", "sentiment_pct": 69, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNbVJXaTY2YkFjX2tldXpxcGpqRm9QRjB4d0ExLUFLWUM5Ym5ubHAzSmdXdk5vb1hrY2NmeC15bG9JS2lZLWFiampjeFh5T3d1eFlfMUVMUlVRRk85M0ppWDllaDlNcHdMR2RfUnpBYmpMT1JmOWV0WU1UUElhSFFpVzBjeWZNWUxnTXVoVTNUb04?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-06-17T13:00:04+00:00", "published_display": "17 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb price gives in to negative pressures - Forecast today - 16-06-2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQeXlLWnJyV25ySU9JNXFnSkQ4TWZQTHE0Vm01SlU2X2dMSFd2YTZxUTNHeTBISGtmNnQ3a3NyZ21BbC0ybnJXbW5ETjV2dGptb21mVFJvMzNKNkpPUmhGcC1KNGQ5TG1hYWRlV0tqYmxVOEctdnlsMk5nOExITEc2ZUtWcVE4Y3p6aDdlQTM5aF9MQ1lqLWlQTTZVMW5uSmdwTk94bzFGa3JNN3A0aHBUWHBTTDNvWmUzZ2s0Z044TnVZYjJycUFGS2wzQU0yMGNKcnFmazJ5S3R2c1A0T3RNTjRRX2k?oc=5", "source_name": "Economies.com", "published_at": "2026-06-16T13:04:00+00:00", "published_display": "16 Jun 2026 13:04", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Stock Could Be 10.7% Undervalued After Kidney Cancer Trial Expansion", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T11:37:22+00:00", "published_display": "16 Jun 2026 11:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Bristol Myers Squibb (BMY) Valuation After Fresh EU Opdivo Approval And New Phase 3 Oncology Data", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T03:36:20+00:00", "published_display": "06 Jun 2026 03:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOLXppNTl1Y0tPaDhXYVJPQ3RUdDA2TVF0YXRldkFOMEJiclE2a3ZXZUFPRkctZ19CRU9JVVdEdElfbHZSN2NKUWRydktMQ00zdm1neWZXTnROb2pyUmM5Ukw0d3FfVl9SM182YkJfN3hjNmtlRGxKY1NjdXNNaVRxVUNadU1FWkdaS1ItV2l1RmNPM2MwQzFtdWJldmg5eDd1VzJB?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: This Pullback Is A Gift For Long-Term Investors (NYSE:BMY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNbU5xN1ZXQ04wWFkwWkE3UThEbVQ3Tl9VQnp6aENOd2tITlRzVEtLT3NMUXREZF9XWk5WRnlKVEotZ3BVdHE4d0JOb3F0elNLLXB0MF82dVpZQlBZdWRyZVlBNnZDVUg1eEtkdl95MXNkN0RrQUZ6Y0ZOYVJUMFlqT3RWM2Vjajdfa2lMdFZ4QUEtYS0tY3RqWVBVcGhCTkp0NmNVM2NHdzVfNmZZWmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bristol-Myers Squibb Stock Underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNZnhCckt2ZlV3Q05hcG5TTVRWVy1xeW1QRWhqaHdXYmtoN2JhYzhXWXh2UTdDOVA4NHIxTEV3WExFS3kzbGRNZDd2d3FKS25yRllpR3VTbGNIVkxGZVo5MTRFdUppcW5jcGJFcEhJSFJFS1ppeXgxb2NrVjhHQkV1LXFSOVBoZ1hHdWVfeXEta004OEdjNXpJOWg3S095aFhpUTYzWEZtX3pHMzA?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSlV5MHVNekNvcy15RXBQdml3eVRkSC01RWJQazVrN3J2Q0ZEUnl5ZXNSNXUtdjViVWN1NHNENjdvMmFDQjVoZXNnc29yRVBVQ3Q1WmoybkVYSkVwd2ZvaF9sMldyM1dLTWM3NXZNbmRVeFVSZXcxTkdiWTY2ZVRsbkRUY2lVWXZ1SEk4dGRSa2ZlcndJakQ0Q2lNcTUyR1ZabnJXa1NxckxoUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQYnVXTkZrUW5ZTDI1UVE1OXdFRVItb3N4akhQOXRTOHZSYndGd1JUcllEN0pHUnRkdlluSHI0ZFliQTRyTlp1NTc3MnNLeVotekxQdy1NQk4zMzNtc1FzM2wzNUVxZEF1b3B1TmVEUWtWdU9hU2VCWnlLNUEyLVpoZDZQUEJodkJ2Nzd3UHY4VUFxQ0JiV0ZVU2p4VzhMcTFr?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS reiterates Bristol-Myers Squibb stock rating on pipeline potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZDJxc3p0MUE4TTA1VVhmTHZBTVU5NFl3OFpLOHpicWh5WnJ6bHhFZzNidGpLV2NJRXh6cnN5QmstQ094bkdyQ1JKRmZwZjVQZnNJV3RtRmI5RHg4RWVMM2dQeWFjUFYwRXpNZEo5Q3J6N1AyWUNBTnNZUHZ1WjhmOWU3cHZTZVZTLXdCaktDbHZyMHljVGJiVzdwVmNwVENFZElHNF9iOEU1N3RTUTUyTi1TeGdJYUJxWEJ2aVVDTjlZTEtkQjhBVA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Made Its Pipeline Case at BofA. Now Comes the Proof.", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZ0RDUllpczhkczI2MUptb2tNOEFfY0J1eU1PR0dVbTZBdDZJeWdpMnlUUjQxU0E3OUlzS3pUQXYzZ3FOYlZHQjJaOXliVzN3NG9odmhlNzdidlE2Wm1QbDBZS0xtQ3R2TkdCSzBMMkpwYWxyODk1NWY0Y0l4c084OVdkNElfOThqV21JakRSRVZPNjhVMFJaamV6dHAwUQ?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift Accurately", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5-Day Sell-Off Sends Bristol-Myers Squibb Stock Down -7.2%", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQRU5kTWFBSzhhTW02aXZ3YXFtQ3VvVHhpZGVVM0FTd0pfNWRKSi1iTFZoQURZQ0g2TmVSeVdaWkt3VkotQlh0bmJZSm1tR0NDUFZRTGotWXhrSzFLZTFKUFVoYlBsN3h4RW9lRWMtMkdxb0FkNzBlVlZaSHlPM3JIamsxaWh1NjFnTmptc3V2bG1qU2dWT2x5MFhtNm9OcEtZR1BtQWRsakhVeGlMVW45c3lwU3M1NVE?oc=5", "source_name": "Trefis", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.18% on May 1: Drivers Behind the Movement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQc25ZX1NFZ1dVRTdERzJMZXlHSlFNME1sdXFBcG4xeTREWTR3ZkxsUmZHODhCbHVvYWUwUHptV3FueWU0MGRocGR5YkZSMXF4S1BrNV9qZGlLclZtaDNpdUFRVzkxbTlJdXRNRS14Uk8tU0hTVjViWm15eE1fbk1xWXlhQy1ReXpVd3c?oc=5", "source_name": "TradingKey", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb Earnings: Steady Quarter Ahead of Multiple Late-Stage Readouts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxOMzdRdl8tTFUxclFnNFc2OC1TZmw4bXZMY1RfX0l2Umk4VDNDNlItaXNVbEZIWWZIUWpfZlczSnVrQ2JLSlo1Y0lqYmowYzlDV002WVV3STVqTng4VWtMQVBjUTRuaEVCdWVoaXVtalJNRklnSEp6LWJkcFlMR0R3ZHpNdHRLWHlna2stU1JzSGtjaWEyRG9Cb2hfZ3RuU0lQWlltOGo1QXJmTzNSR2otWjJaZ0JwLWhicHVWX2xTNER6Q1hHa2NJTnJlRHY3NzVUNkdYZHpQbDNqTXU5dGVUZU5sY1dDeVFO?oc=5", "source_name": "Morningstar", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb: Value Stock Analysis for Dividend Investors in 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxORVJTMFFLdjhIRzlaempPalJuQ3YxSkEwLXFkZ2xyblBwOHdsWXpvbmozbHFkLXNNLWJxUUctOVlaYllwa1I3NEFtLVkybG4yQXFHZVRRTTZ2endOeHFaQTIxSDhkZ0hobjk5b3l6VDRvSnR0Sk1YdVBVUXNwUUQxa1gweXJMVV9ncXVnUC1FZlZXdw?oc=5", "source_name": "IndexBox", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPZmJKQ3l2S2FkYjlsd0xiQWUwX1V5d3R2cEMzblBrVmNTUEdtdWFndkl6UnAyOTVQYW96VGdiQzlaX3dwQ0FjSUNHVE9mSy1kLTlhX29HUmFfcG55ZlRRV2lfcGl2S2l5ZXc0TUZwcmFxRGFHVjJyWW9EMXk4UVFWRUxQMEZybElFTll6NjNsNUxKcUJ6cEE2aTZPYXpMYXhYRm51LTRlRHp2RXIzQjFfSG1Wc3pVcFkyRVZaUjduTjFOWlZ5TmV1Q1VKWUdPREtlbW5sX3c3MkltOWVXRWlHMEdUSnBBTllFRjQ3bFkwSndnc2FiZFlkOHhB?oc=5", "source_name": "StockStory", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxObGRGcDE1QmFuUy1IX0l2TjZoeUptM3lLTlJxZjRBNjlvY01CT0pnTzVRN1EwU2pvRERsQUFTTENEU0VVUTB5TlZXQU5YWnVXVnY4bnNlNHg3c0wxakJ1NG0xV3FRZFFFYTRCSGMyc3dINmxkeXNHVXJUTTIycFR5U1F6Y3M1dmJzMjJTM1JETmswTHpaSjNmYnlaeXA0Zw?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Bristol-Myers Squibb (BMY) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbDNiVDQ1OWZITy1VZXJIUURiOXBvSDZfSTA4Q0ZOTkotRks1a2tqOEJpYU9zSFpSWWxvdlVBQXFxRjFyWWdtMkI4Y1d0MHQyN2pyaS1hN0Q2Rm5uUkVpQXREZU9QS2lrSG5sbG14SkZRUXZ3eGN5UktRWUhTcmU1STdueXJsQ0FKajUxYWhKUkVUNFpNVzhlOWpnNGdBOENhWTFxemVDMEx3c1U?oc=5", "source_name": "StockStory", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Like Bristol-Myers Squibb's (NYSE:BMY) Earnings For More Than Just Statutory Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 108, "total_relevant": 39, "sentiment_summary": {"positive": 13, "negative": 3, "neutral": 23, "score": 56, "total": 39, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 10.95, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 5.3, "count": 9}, {"event": "capital_return", "label": "Capital return", "weight": 3.85, "count": 7}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 54.0, "latest_week": "2026-06-19", "one_week_move": -5.5, "four_week_move": -9.2, "twelve_week_move": -6.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.086833, "market_dynamics_buy_signal": false, "relative_strength": -5.483418, "fair_value_gap": 9.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.7151, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.5% over one week, -9.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "simplywall.st", "count": 6}, {"label": "MarketWatch", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "marketscreener.com", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "The Motley Fool", "count": 1}, {"label": "Bristol Myers Squibb", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 39}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 9}, {"label": "Capital return", "count": 7}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "39", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.5% over one week, -9.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "3 Reasons to Buy Bristol Myers Squibb Stock"}], "updated_at": "2026-06-23T05:47:29.609122+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}